Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome.
Livia CosentinoChiara UrbinatiChiara LanzillottaDomenico De RasmoDaniela ValentiMattia PellasMaria Cristina QuattriniFabiana PiscitelliMagdalena KostrzewaFabio Di DomenicoDonatella PietraforteTiziana BisognoAnna SignorileRosa Anna VaccaBianca De FilippisPublished in: Molecular autism (2024)
The present data identify mtCB1R overexpression as a novel molecular alteration in the RTT mouse brain that may underlie defective brain mitochondrial bioenergetics and cognitive dysfunction.